FdaApplication
ANDA 091426
Identifiers
- fda_app_no: ANDA091426
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2010-07-02 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SPIRONOLACTONE | SPIRONOLACTONE | 100MG | TABLET;ORAL |
| SPIRONOLACTONE | SPIRONOLACTONE | 25MG | TABLET;ORAL |
| SPIRONOLACTONE | SPIRONOLACTONE | 50MG | TABLET;ORAL |
3 products